Liftstream is an executive search recruitment company in the life sciences sector
Novimmune sees immunotherapy and orphan focus attract new capital
Authored by Karl Simpson
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases
Tagged acute lymphocytic leukemia, Alexion, Angel investment, Ariad, bioValley, Covagen, Crohn's disease, Dr Jonathan hepple, Geneva, Hemophagocytic lymphohistiocytosis, Lomard odier ventures, Merck Serono, monoclonoal antibody therapeutics, NovImmune, Nyon, Rare Disease, renal allograft transplantation, Rosetta Capital, Shire, Switzerland, Vertex Pharmaceuticals, Zug
Leave a comment